has acted as consultant, advisory board member and speaker for Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi, an advisory board member Lexicon, Pfizer, ShouTi Pharma Inc, AstraZeneca and Medtronic and as a speaker for AstraZeneca, Napp Pharmaceuticals, Novartis and Amgen
All devices, fluids, nutrients, and drugs used in BOOST therapies are approved as either a Medical Device (MDL), Drug (DIN), or Natural Health Product (NPN)
In dermalen und kornealen Modellen beschleunigt Tb4 die Reepithelialisierung (Malinda et al., J Invest Dermatol , 1999
Although the increase in uric acid concentration did not cause any visible health complications in the examined volunteers, it should be considered as an unfavourable effect
Two medicines that influence appetite can create layered effects, even when each one seems understandable on its own
6 In the brain, that antioxidant support matters for the neural pathways involved in focus, recall, and mental energy